The India malaria diagnostics market size reached USD 28.65 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 46.39 Million by 2033, exhibiting a growth rate (CAGR) of 5.50% during 2025-2033.The implementation of favourable government initiatives, continual technological advancements, and increased awareness about early disease detection are some of the major factors expanding the India malaria diagnostics market share. The adoption of rapid diagnostic tests (RDTs) and molecular diagnostics is expanding, driven by efforts to achieve malaria elimination, further contributing to market growth.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 28.65 Million |
Market Forecast in 2033 | USD 46.39 Million |
Market Growth Rate 2025-2033 | 5.50% |
Growing Preference for Rapid Diagnostic Tests (RDTs) in Malaria Detection
The India malaria diagnostics market growth is driven by a significant shift toward rapid diagnostic tests (RDTs) due to their ease of use, affordability, and quick results. RDTs help detect malaria within minutes without the need for specialized equipment or trained technicians, making them ideal for use in rural and remote areas. According to an industry report, persistent efforts over the decades have severely reduced these figures by almost 97%, with cases declining to just 2 million and deaths plummeting to just 83 by 2023. According to an industry report, persistent efforts over the decades have severely reduced these figures by almost 97%, with cases declining to just 2 million and deaths plummeting to just 83 by 2023. The significant reduction in malaria cases and deaths significantly impacts the malaria diagnostics market in India. Also, the implementation of government initiatives like Malaria Elimination Goal 2030 encourages the adoption of RDTs. Additionally, continual advancements in RDT technology are improving accuracy and sensitivity, reducing the chances of false positives or negatives. The rising awareness of early malaria detection, coupled with an increase in point-of-care testing, is fueling the demand for these tests. With ongoing efforts, RDTs are expected to play a critical role in strengthening India’s diagnostic infrastructure, ensuring faster detection, and ultimately helping to control the spread of the disease in endemic areas.
Government and Private Sector Collaboration Boosting Malaria Diagnostics
The market in India is benefiting from strategic collaborations between the government, private healthcare providers, and global organizations. Government programs like the National Strategic Plan for Malaria Elimination (2017-2030) are significantly increasing access to diagnostic tools across the country. Additionally, partnerships with private diagnostic companies are ensuring a steady supply of affordable and high-quality malaria test kits. International organizations, such as the World Health Organization (WHO) and the Global Fund, are also providing financial and technical support to enhance malaria detection efforts. Investments in modern diagnostic technologies, such as molecular testing and mobile health solutions, are further strengthening surveillance and early detection, which is positively impacting the India malaria diagnostics market outlook. These collaborations are not only improving malaria testing facilities but also ensuring that even the most underserved regions receive timely and effective diagnostic support. According to an industry report, India aims to achieve zero indigenous malaria cases by 2027. Initiatives like the Intensified Malaria Elimination Project-3 (IMEP-3) specifically target vulnerable populations across 159 districts in 12 states, driving the need for robust diagnostic tools to ensure early detection and treatment. The government is also allocating resources for strengthening surveillance systems, advancing entomological research, and distributing long-lasting insecticidal nets (LLINs), which enhance the effectiveness and sustainability of malaria eradication efforts. To further accelerate progress, public-private partnerships are formed to expand diagnostic access, particularly in underserved regions. These collaborations are fostering innovation and ensuring accurate and timely identification of cases. As a result, India is making steady progress toward reducing malaria cases and moving closer to its elimination goals.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on technology and molecular diagnostic tests.
Technology Insights:
The report has provided a detailed breakup and analysis of the market based on the technology. This includes microscopy, rapid diagnostic tests (RDT), and molecular diagnostic tests.
Molecular Diagnostic Tests Insights:
A detailed breakup and analysis of the market based on the molecular diagnostic tests have also been provided in the report. This includes conventional PCR and modernized PCR.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Technologies Covered | Microscopy, Rapid Diagnostic Tests (RDT), Molecular Diagnostic Tests |
Molecular Diagnostic Tests Covered | Conventional PCR, Modernized PCR |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |